Prior studies have demonstrated that elevated RAC3 levels in epithelial cancer tissues are inversely linked to the infiltration of CD8+T cells, thereby orchestrating a microenvironment that suppresses the immune response and targeting RAC3 offers a strategic approach to reconfigure the immune microenvironment, thereby amplifying the potency of immune cells in combating tumor growth (41). Here, RAC3 is linked to neoplasm.